Personalized approaches could be implemented based on individual risk profiles, including, e.g., age, genetic predisposition (such as APOE-ε4 allele), family history of memory impairment, comorbidities, and other specific modifiable risk factors, with interventions tailored and delivered in a manner that can be sustained by the individual. This evidence concerns the gene APOE and memory impairment.